Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PowerVision is a medical device company specializing in the development of fluid-based accommodating intraocular lenses (IOLs) designed to treat cataracts and presbyopia. The company's flagship technology, FluidVision, utilizes the eye's natural muscle contractions to move fluid within the lens, mimicking the natural focusing ability of a youthful eye. This approach aims to provide a continuous range of vision and reduce dependence on glasses following cataract surgery. In 2019, PowerVision was acquired by Alcon for $285 million plus future milestones to bolster Alcon's advanced technology IOL portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PowerVision Robot.